GL1X · GenesisL1 explorer

Research workbench

PCSK9(DELTACRD) in complex with phage-derived inhibitory peptide 2-8

Analyse PCSK9(DELTACRD) in complex with phage-derived inhibitory peptide 2-8 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4NMX
Type
protein
Length
383 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proprotein convertase SUBTILISIN/KEXIN type 9; Peptide 2-8
EC
3.4.21.-
UniProt
Q8NBP7
Ligands
ACE, NH2
Pockets
2 · best druggability 0.31

Structure

x-ray diffraction · 3 distinct chains · 31% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProprotein convertase SUBTILISIN/KEXIN type 9protein9230% helix, 39% strandQ8NBP7
BProprotein convertase SUBTILISIN/KEXIN type 9 (EC 3.4.21.-)protein27829% helix, 25% strandQ8NBP7
ZPeptide 2-8protein1354% helix, 8% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains B, Z
  • NH2 · Amino group · ion · chains Z

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1690.310.7518empty
2600.260.7218empty

Interfaces

2 interfaces between chains.

  • A–B · 1341 Ų buried · 28 hydrogen bonds · protein-protein
  • B–Z · 414 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 disulfide, 1 covalent (disulfide, covalent ligand).

Compared structures

  • 4NMX · PCSK9(deltaCRD) in complex with phage-derived inhibitory peptide 2-8 · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.